Clinical Study Map: Women's Health Supplement

The document evaluates the effectiveness and safety of nutritional and herbal supplements for women's health, focusing on menopause, pregnancy-related health, and hormonal imbalances. It highlights findings from the Women's Health Initiative, which involved over 160,000 postmenopausal women, showing that hormone therapy increased risks of breast cancer and cardiovascular issues, while calcium and vitamin D improved bone health modestly. The study emphasizes the need for personalized supplementation strategies tailored to women's physiological needs across life stages and calls for rigorous, long-term studies to address research gaps, particularly in vaginal microbiota and prenatal nutrition. It also discusses best practices for clinical trials, stressing diversity, ethical considerations, and the importance of patient-reported outcomes. The document underscores the evolving landscape of women's health supplements, driven by scientific advancements and personalized nutrition approaches, with a market projected to reach $316 billion by 2035.